Monosemicarbazone Adrenochrome: Brands, Price & Uses in Bangladesh

Monosemicarbazone Adrenochrome is a hemostatic (antihemorrhagic) and capillary-protective agent used to help reduce oozing-type bleeding related to increased capillary fragility and permeability. Its use can be classified by strength of supporting evidence as follows:

Established/commonly used indications

• Reduction of capillary bleeding (oozing) during and after minor surgical, dental, ENT (e.g., tonsillectomy), and gynecological procedures, used as an adjunct alongside standard surgical hemostatic technique.
• Management of bleeding associated with increased capillary fragility, such as purpura and easy bruising of capillary origin.
• Symptomatic control of epistaxis (nosebleeds) of capillary origin, as an adjunct to standard first-aid measures.

Adjunct / combination-therapy uses

• As an adjunct to other hemostatic measures (e.g., local pressure, packing, or definitive surgical hemostasis) rather than as a stand-alone treatment for significant or ongoing hemorrhage.
• Adjunctive use in menorrhagia (heavy menstrual bleeding) believed to be related to capillary fragility, typically alongside other gynecologic management.

Uses with limited/evolving evidence

• Use in hemorrhoidal bleeding and some ophthalmic (retinal/vitreous) capillary hemorrhage settings has been explored, but supporting evidence is less robust and use is considered adjunctive/off-label in these settings.

Monosemicarbazone Adrenochrome is not a substitute for identifying and treating the underlying cause of significant bleeding, nor for definitive surgical or coagulation-based hemostatic intervention when these are required.

Dosing of Monosemicarbazone Adrenochrome is individualized by indication, route, and clinical response, and should always be directed by a physician.

Pediatric Dose

Safety and efficacy of Monosemicarbazone Adrenochrome have not been well established in children; if a physician determines it is needed, a reduced dose under close specialist supervision is used.

Renal/Hepatic Impairment

No well-established dose-adjustment guidelines exist for renal or hepatic impairment; use Monosemicarbazone Adrenochrome with caution and physician oversight in these populations.

Monosemicarbazone Adrenochrome is generally well tolerated. Reported adverse effects are usually mild and infrequent, and may include:

• Nausea or mild gastrointestinal discomfort (with oral use)
• Skin rash or hypersensitivity reactions
• Injection-site pain, redness, or irritation (with injectable use)
• Headache or dizziness (uncommon)

Seek medical attention if signs of a serious allergic reaction (e.g., swelling of the face/throat, difficulty breathing, widespread rash) occur while taking Monosemicarbazone Adrenochrome.